This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One of the most significant modifications that middle-aged patients can take to prevent cardiovasculardisease is lowering arterial hypertension, according to research presented during a Featured Clinical Research Session at ACC.25 25 in Chicago and simultaneously published in NEJM.
Every year, the AHA reports the most up-to-date statistics related to heart disease, stroke, and cardiovascularriskfactors. is at an all time high, with 942k cardiovasculardisease-related deaths in 2022, up by 10k from 2021. as of 2020) have some form of CVD (comprising CHD, HF, stroke, and hypertension).
Cardiovascular mortality is still excessively high, despite the considerable progress made in the prevention and treatment of cardiovasculardiseases. Although many cardiovascularriskfactors (such as arterial hypertension, hypercholesterolemia, diabetes, etc.),
Objectives To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 vs. 51.6 ± 14.7
We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% Prevalences of coronary disease (7.8% to 2.4%), and total cardiovasculardisease (11.3%
Atherosclerosisa key driver of cardiovasculardisease (CVD)continues to be a significant global health issue. The Global Burden of Disease data (2023) highlights a grim reality: while high-income countries have seen some success in managing CVD, LMICs now account for most CVD-related deaths.
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the riskfactors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovasculardisease.
BackgroundThe relationship between resting heart rate (RHR) and the risk of end‐stage renal disease (ESRD) among those without cardiovasculardisease remains unclear. The risk of ESRD remained significantly elevated (HR, 1.32 [95% CI, 1.10–1.58]
This troubling trend has cemented the 100-year reign of cardiovasculardiseases (CVD) as the #1 killer in America. 1 Peeling back the layers of Social Determinants of Health (SDOH) Despite medicine and science advancing leaps and bounds, in 2024, cardiovasculardisease remains the leading cause of death in America.
We need to do better if we want to majorly impact rates of cardiovasculardisease worldwide. Like other riskfactors for heart disease, the key is to maintain normal blood pressure for as long as possible. 1 The global epidemiology of hypertension. Hypertension. Hypertension. It is not enough.
Background Current clinical guidelines on cardiovasculardisease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD in women. Results After two rounds, consensus in agreement was reached on 27 items (61.4%).
Hypertension, Ahead of Print. BACKGROUND:Orthostatic hypertension is an emerging riskfactor for adverse events. These differences in CVD risk raise important concerns about combining systolic orthostatic increases and standing SBP 140 mm Hg in a consensus definition for orthostatic hypertension.
February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovasculardisease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. per 1,000* - 122.4
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascularriskfactor or condition in 2020.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following riskfactors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
Objective Observational studies show that hypertensive disorders of pregnancy (HDPs) are related to unfavourable maternal cardiovasculardisease (CVD) risk profiles later in life. to 1.38) per unit increase in the log odds of genetic liability to pre-eclampsia/eclampsia and gestational hypertension, respectively.
Cardiovasculardisease (CVD) is the leading cause of death worldwide, accounting for over one-third of all deaths in Singapore. Furthermore, other major riskfactors, such as diabetes mellitus, hypertension, elevated low-density lipoprotein levels, and obesity, are steadily rising. billion USD (11.5 billion SGD).
Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovasculardisease. White) to assess their CKM stages, finding the following breakdown: Stage 0 (no riskfactors) – 10.6% in Whites).
Pre-eclampsia and heart failure have common riskfactors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia. This study examines whether pregestational heart failure increases the risk of pre-eclampsia.
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. to 61% of the U.S.
A substantial gap was found between the self-reports of cardiovasculardisease (CVD) by former players in the National Football League (NFL) and a "surprisingly high" prevalence of hypertension, with a "significant discrepancy between participants' awareness and observed disease prevalence," according to the findings.
Heart Health: Understanding and Diagnosing Disease by Leveraging Echocardiograms was aimed to raise awareness and estimate the prevalence of cardiovasculardisease and associated riskfactors among members of the United States, National Football League Alumni Association and their family members through education and screening events.
Hypertensive disorders of pregnancy as a riskfactor for heart failure. BMI, body mass index; CV, cardiovascular; CVD, cardiovasculardisease; HELLP, haemolysis, elevated liver enzymes, low platelet count.
As a riskfactor, it is responsible for more early deaths than any other riskfactor 1. If we are going to make a dent in the riskfactor that drives the greatest amount of premature mortality worldwide, we need to do a better job of identifying and managing high blood pressure. But here is the real problem.
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major riskfactor for cardiovasculardiseases and chronic kidney disease.
Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovasculardisease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.
Aims:Asian Americans experience disproportionate burdens of cardiovascularriskfactors and cardiovasculardisease (CVD). However, the trends in cardiovascularrisks in adults from different Asian ethnic backgrounds remain understudied.
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascularriskfactors.
Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovasculardisease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD riskfactors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.
Hypertension, Ahead of Print. Blood pressure guidelines serve as a beacon of best practice for the diagnosis and management of hypertension. The many cultural and societal differences in hypertensionriskfactors and management patterns across geographic regions support the need for geographically distinct international guidelines.
Elevated blood pressure (BP) is a major modifiable riskfactor for stroke and cardiovasculardisease. Yet progress on controlling hypertension and reducing death and disability from stroke and cardiovasculardisease has stalled.
An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovasculardisease, and this prevalence is unchanged over time. said Michael Miedema, MD, MPH , director of the Nolan Family Center for Cardiovascular Health at MHIF and senior author of the research.
Background and objectives Hypertension is one of the most serious riskfactors and the leading cause of mortality in patients with cardiovasculardiseases (CVDs). It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension.
Hypertension, Ahead of Print. Hypertension, a leading cause of cardiovasculardisease and premature death, remains incompletely understood despite extensive research. The challenges and limitations associated with data-driven predictive techniques are also discussed.
The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high blood pressure, in older adults without increasing their risk of low blood pressure episodes, according to a study published in the Feb. All participants had blood pressure At two years, the incidence of hypertension was 11.7
Background and aims Hypertension is a leading riskfactor for cardiovasculardisease. This study aimed to identify codelists used to define hypertension in studies that use EHRs and generate recommended codelists to support reproducibility and consistency. EHRs can be used for epidemiological research.
Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and RiskFactors. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.
Background High blood pressure (BP) is a major riskfactor for cardiovasculardisease (CVD). Adequate treatment of high BP should reduce the risk of CVD, but this association has seldom been assessed in a general population setting.
Background Left ventricular hypertrophy (LVH) is frequently seen in association with arterial hypertension and indicates poor prognosis. This study aimed to determine the prevalence of LVH and associated factors in a multiethnic population from Mauritius. to 1.75)), hypertension (3.01 (2.55 to 1.75)), hypertension (3.01 (2.55
Obesity, a major riskfactor for cardiovasculardisease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.
BackgroundRING finger protein 213 (RNF213) p.R4810K is an established riskfactor for moyamoya disease and intracranial artery stenosis in East Asian people. Recent evidence suggests its potential association with extracranial cardiovasculardiseases, including pulmonary hypertension.
BACKGROUND:The relationship between marijuana use and cardiovascular health remains uncertain, with several observational studies suggesting a potential association with increased adverse atherosclerotic cardiovasculardisease (ASCVD) outcomes. Likewise, mean 10-year ASCVD risk scores (2.8% were current users. P=0.76; 79.8%
Hypertension, Ahead of Print. BACKGROUND:Hypertension is a major cardiovascularriskfactor, yet traditional care often results in suboptimal blood pressure (BP) control at the population level. We implemented a remote hypertension management program that monitored home BP and titrated medications per algorithm.
Hypertension, Volume 80, Issue 12 , Page 2506-2514, December 1, 2023. billion people worldwide suffer from arterial hypertension, a significant riskfactor for cardiovasculardisease which is now the leading cause of death.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content